Date published:
PHI circular type:
PHI announcement
Audience:
Health sector
This circular is to advise stakeholders of the publication of the interim evaluation report 1 of the Prescribed List reforms.
This interim evaluation report 1 covers the period from May 2021 to June 2024. It builds on the baseline evaluation report and reports on whether the reforms are:
- being implemented as intended
- achieving the expected outcomes
The interim evaluation report 1 was prepared by an independent reviewer, following feedback from the Prescribed List reform Evaluation Advisory Group.
Read more on the evaluation of the Prescribed List reforms